Hematogenous and lymphatic tumo ...
Tumor cell dissemination in bone marrow (BM) and lymph nodes is considered an important step in systemic disease progression and is associated with ...
FOXA1 is an independent prognos ...
Forkhead box protein A1 (FOXA1) is a ‘‘pioneer factor’’ that plays a role in controlling nearly 50% of estrogen receptor target genes. FOXA1 express ...
COX2 overexpression is a progno ...
To determine the significance of (Cyclooxygenase 2) COX2 for clinical outcome in breast cancer, we analyzed the correlation between COX2 overexpress ...
Overexpression of ligase defect ...
E6-associated protein (E6-AP) is a dual function protein. It acts as an E3 ubiquitin-protein ligase enzyme and coactivator of steroid hormone recept ...
Absenteeism and short-term disa ...
Few data exist related to the impact of breast cancer on work absenteeism and short-term disability. This retrospective study estimated the extent a ...
Transcriptomic and proteomic pr ...
Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a potent inhibitor of experimental mammary carcinogenesis and may be an ef ...
Prevalence and characterization ...
Although there are some studies to investigate germline mutations in BRCA1/2 genes in Chinese women with familial breast cancer, many of them suffer ...
Characterisation of unclassifie ...
subset of the unclassified variants (UVs) identified during genetic screening of BRCA1/2 genes may affect splicing. We assessed at RNA level the eff ...
A prognostic model for lymph no ...
model for a more precise prognosis of the risk of relapse is needed to avoid overtreatment of lymph node-negative breast cancer patients. A large de ...
Identification of the receptor ...
The identification of molecular features that contribute to the progression of breast cancer can provide valuable insight into the pathogenesis of t ...
Predictors of timing of adjuvan ...
Adherence to consensus guidelines for cancer care may vary widely across health care settings and contribute to differences in cancer outcomes. For ...
Gene expression profile testing ...
As gene expression profile (GEP) testing for breast cancer may provide additional prognostic information to guide the use of adjuvant chemotherapy, ...
Different CHEK2 germline mutati ...
Germline mutations in BRCA1 were already linked to basal-like subtype of immunophenotypic molecular classification of breast cancer (BC). However, i ...
A SEER-Medicare population-base ...
Each year there are an estimated 200,000 new breast cancer cases diagnosed in the United States; of these, 1% of cases are in men. Lymphedema can be ...
Common genetic polymorphisms of ...
Recent compelling evidence indicates that mutation, aberrant expression, and dysregulation of microRNA (miRNA) biogenesis are implicated in cancer ...
Co-expression of SNAIL and TWIS ...
Epithelial mesenchymal transition (EMT) plays an important role in the development of metastases. One of the hallmarks of EMT is loss of E-cadherin ...
b-Adrenergic receptors (b-AR) r ...
Activation of b-adrenergic receptors (b-AR) drives proangiogenic factor production in several types of cancers. To examine b-AR regulation of breast ...
The prognostic role of circulat ...
The prognostic significance of circulating tumor cells (CTCs) in patients with breast cancer is controversial. We performed a meta-analysis of publi ...
Traditional breast cancer risk ...
At least four major categories of invasive breast cancer have been reproducibly identified by gene expression profiling: luminal A, luminal B, HER2- ...
Loss of Yes-associated protein ...
Yes-associated protein (YAP) is a well characterized transcriptional coactivator that interacts with various transcription factors and modulates the ...
FOXC1, a target of polycomb, in ...
Polycomb group (PcG) proteins have recently been shown related to cancer development. The PcG protein EZH2 is involved in progression of prostate an ...
KX-01, a novel Src kinase inhib ...
KX-01 is the first clinical Src inhibitor of the novel peptidomimetic class that targets the peptide substrate site of Src providing more specificit ...
Second events following ductal ...
The incidence of ductal carcinoma in situ (DCIS) of the breast has increased in recent decades, particularly, in counties offering mammography scree ...
Correlates of fear of cancer re ...
Fear of cancer recurrence (FCR) is a common and persistent concern among breast cancer survivors. Little is known about factors associated with FCR ...
Sleep duration change across br ...
Sleep duration among breast cancer survivors correlates with fatigue, depression, and health-related quality of life (HRQOL); however, this has not ...